See also this year's filing and all EDGAR filings for this company.
PDF Report 0001370053_2019_Anaptysbio_INC.pdf
Logs
Graph
Absolute values for 0001370053, Anaptysbio INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 434,216,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,445,000 |
| 3 | remainder_Assets | 73,336,000 |
| 4 | LiabilitiesCurrent | 21,836,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,526,000 |
| 9 | ResearchAndDevelopmentExpense | 56,196,000 |
| 10 | remainder_Expenses | -192,000 |
| 11 | remainder_Revenues | 5,000,000 |
| 12 | remainder_NetIncome | 4,874,000 |
| 13 | remainder_ComprehensiveNetIncome | 203,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 508,997,000 |
| 1 | Liabilities | 21,836,000 |
| 2 | Expenses | 71,530,000 |
| 3 | Revenues | 5,000,000 |
| 4 | StockholdersEquity | 487,161,000 |
| 5 | NetIncome | -61,656,000 |
| 6 | ComprehensiveNetIncome | -61,554,500 |
| 7 | BaseVar | 306,220,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.77 |
| 9 | EconomicCapitalRatio | 4.22 |